{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:03:26Z","timestamp":1780524206973,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Functional constipation is common in children and often responds poorly to standard treatments. This study evaluated the efficacy and mechanisms of multi-strain\n                      <jats:italic>Bacillus<\/jats:italic>\n                      spore probiotics, which tolerate gastrointestinal conditions, in paediatric functional constipation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a randomized, double-blind, placebo-controlled trial (ClinicalTrials.gov NCT06154525, 4\/12\/2023) in preschool children (24\u201360 months) with functional constipation in Vietnam. A total of 111 participants were randomly assigned (1:1:1) to receive placebo or two multi-strain\n                      <jats:italic>Bacillus<\/jats:italic>\n                      spore probiotics (LiveSpo Kids or Preg-Mom, \u22653 billion CFU\/5\u2009mL registered; each tested at 3.7 billion CFU\/5\u2009mL) for 28 days. Primary outcomes were changes in functional constipation (main focus), anorexia, and underweight risk at day 28. Secondary outcomes included serum cytokines, stool IgA, and gut microbiota; stool samples from 10 healthy children provided a reference microbiota profile.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Both probiotic groups show significant improvements at day 28. Percentages of children with constipation decrease 3.7-fold in Kids and 5.1-fold in PregMom (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Absolute Risk Reductions (ARR) are 52.38% (95%CI: 35.45%-77.26%) and 59.97% (95%CI: 44.48%-84.68%) in Kids and PregMom vs Placebo. Kids and PregMom groups improve anorexia (ARR: 24.40% (95%CI: 3.09%-49.44%) and 25.98% (95%CI: 4.69%-51.25%)) and underweight risk (ARR: 7.87% (95%CI: 0%-23.80%) and 19.30% (95%CI: 1.70%-37.50%)) vs. Placebo. Probiotics reduce serum IL-6 and IL-23, increase IL-10 and stool IgA, and shift the gut microbiota toward a composition more closely resembling healthy children, enriching beneficial species while reducing harmful ones.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Multi-strain\n                      <jats:italic>Bacillus<\/jats:italic>\n                      spore probiotics alleviate functional constipation, improve immune markers, and modulate gut microbiota in children, supporting their potential as effective microbiome-targeted interventions.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s43856-026-01517-6","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:02:42Z","timestamp":1773828162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bacillus spore probiotics for alleviating functional constipation in children: a randomized, double-blind, placebo-controlled trial"],"prefix":"10.1038","volume":"6","author":[{"given":"Hanh Thi Luong","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang Thi","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dung Phuong","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truong Quoc","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc Thi Ho","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai Tuyet","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung Trong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4590-4479","authenticated-orcid":false,"given":"Anh Hoa","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0552-2142","authenticated-orcid":false,"given":"Tung Dinh","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1215-6910","authenticated-orcid":false,"given":"Anh Thi Van","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"1517_CR1","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3748\/wjg.v29.i8.1261","volume":"29","author":"DL Tran","year":"2023","unstructured":"Tran, D. L. & Sintusek, P. Functional constipation in children: what physicians should know. World J. Gastroenterol. 29, 1261\u20131288 (2023).","journal-title":"World J. Gastroenterol."},{"key":"1517_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41575-019-0222-y","volume":"17","author":"MH Vriesman","year":"2020","unstructured":"Vriesman, M. H., Koppen, I. J. N., Camilleri, M., Di Lorenzo, C. & Benninga, M. A. Management of functional constipation in children and adults. Nat. Rev. Gastroenterol. Hepatol. 17, 21\u201339 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1517_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58642-2","volume":"14","author":"M Kwiatkowska","year":"2024","unstructured":"Kwiatkowska, M., Golebiewski, M., Sikora, M., Rycharska, E. L. & Krogulska, A. The oral cavity and intestinal microbiome in children with functional constipation. Sci. Rep. 14, 8283 (2024).","journal-title":"Sci. Rep."},{"key":"1517_CR4","doi-asserted-by":"publisher","first-page":"6899","DOI":"10.1007\/s00253-022-12197-2","volume":"106","author":"L Yang","year":"2022","unstructured":"Yang, L. et al. Gut microbiota: a new avenue to reveal pathological mechanisms of constipation. Appl. Microbiol. Biotechnol. 106, 6899\u20136913 (2022).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"1517_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan, Y. & Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 19, 55\u201371 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"1517_CR6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill, C. et al. Expert consensus document. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11, 506\u2013514 (2014).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1517_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.it.2024.01.006","volume":"45","author":"M Bemark","year":"2024","unstructured":"Bemark, M., Pitcher, M. J., Dionisi, C. & Spencer, J. Gut-associated lymphoid tissue: a microbiota-driven hub of B cell immunity. Trends Immunol. 45, 211\u2013223 (2024).","journal-title":"Trends Immunol."},{"key":"1517_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nri3430","volume":"13","author":"N Kamada","year":"2013","unstructured":"Kamada, N., Seo, S. U., Chen, G. Y. & Nunez, G. Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 13, 321\u2013335 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"1517_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41575-021-00563-w","volume":"19","author":"O Pabst","year":"2022","unstructured":"Pabst, O. & Izcue, A. Secretory IgA: controlling the gut microbiota. Nat. Rev. Gastroenterol. Hepatol. 19, 149\u2013150 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1517_CR10","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00431-017-2972-2","volume":"176","author":"K Wojtyniak","year":"2017","unstructured":"Wojtyniak, K. & Szajewska, H. Systematic review: probiotics for functional constipation in children. Eur. J. Pediatr. 176, 1155\u20131162 (2017).","journal-title":"Eur. J. Pediatr."},{"key":"1517_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41430-020-00754-9","volume":"75","author":"TT Mai","year":"2021","unstructured":"Mai, T. T. et al. Efficacy of probiotics on digestive disorders and acute respiratory infections: a controlled clinical trial in young Vietnamese children. Eur. J. Clin. Nutr. 75, 513\u2013520 (2021).","journal-title":"Eur. J. Clin. Nutr."},{"key":"1517_CR12","volume":"3","author":"C Wallace","year":"2022","unstructured":"Wallace, C. et al. Probiotics for treatment of chronic constipation in children. Cochrane Database Syst. Rev. 3, CD014257 (2022).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1517_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1323521","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Probiotics for functional constipation in children: an overview of overlapping systematic reviews. Front. Cell Infect. Microbiol. 13, 1323521 (2023).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"1517_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41575-019-0173-3","volume":"16","author":"ME Sanders","year":"2019","unstructured":"Sanders, M. E., Merenstein, D. J., Reid, G., Gibson, G. R. & Rastall, R. A. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat. Rev. Gastroenterol. Hepatol. 16, 605\u2013616 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1517_CR15","doi-asserted-by":"publisher","first-page":"e2436888","DOI":"10.1001\/jamanetworkopen.2024.36888","volume":"7","author":"J Cheng","year":"2024","unstructured":"Cheng, J. et al. Eight-week supplementation with Bifidobacterium lactis HN019 and functional constipation: a randomized clinical trial. JAMA Netw. Open 7, e2436888 (2024).","journal-title":"JAMA Netw. Open"},{"key":"1517_CR16","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s10068-019-00691-9","volume":"28","author":"NK Lee","year":"2019","unstructured":"Lee, N. K., Kim, W. S. & Paik, H. D. Bacillus strains as human probiotics: characterization, safety, microbiome, and probiotic carrier. Food Sci. Biotechnol. 28, 1297\u20131305 (2019).","journal-title":"Food Sci. Biotechnol."},{"key":"1517_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51823-z","volume":"14","author":"M Golnari","year":"2024","unstructured":"Golnari, M. et al. Isolation and characterization of novel Bacillus strains with superior probiotic potential: comparative analysis and safety evaluation. Sci. Rep. 14, 1457 (2024).","journal-title":"Sci. Rep."},{"key":"1517_CR18","doi-asserted-by":"publisher","unstructured":"Ahire, J. J., Kashikar, M. S. & Madempudi, R. S. Survival and germination of Bacillus clausii UBBC07 spores in in vitro human gastrointestinal tract simulation model and evaluation of clausin production. Front. Microbiol. 11 https:\/\/doi.org\/10.3389\/fmicb.2020.01010 (2020).","DOI":"10.3389\/fmicb.2020.01010"},{"key":"1517_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.715863","volume":"12","author":"J Colom","year":"2021","unstructured":"Colom, J. et al. Presence and germination of the probiotic Bacillus subtilis DE111((R)) in the human small intestinal tract: a randomized, crossover, double-blind, and placebo-controlled study. Front. Microbiol. 12, 715863 (2021).","journal-title":"Front. Microbiol."},{"key":"1517_CR20","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.3389\/fmicb.2017.01666","volume":"8","author":"ON Ilinskaya","year":"2017","unstructured":"Ilinskaya, O. N., Ulyanova, V. V., Yarullina, D. R. & Gataullin, I. G. Secretome of intestinal Bacilli: a natural guard against pathologies. Front. Microbiol. 8, 1666 (2017).","journal-title":"Front. Microbiol."},{"key":"1517_CR21","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41579-021-00540-9","volume":"19","author":"S Arnaouteli","year":"2021","unstructured":"Arnaouteli, S., Bamford, N. C., Stanley-Wall, N. R. & Kovacs, A. T. Bacillus subtilis biofilm formation and social interactions. Nat. Rev. Microbiol. 19, 600\u2013614 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"1517_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12979-015-0051-y","volume":"12","author":"M Lefevre","year":"2015","unstructured":"Lefevre, M. et al. Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebo-controlled study. Immun. Ageing 12, 24 (2015).","journal-title":"Immun. Ageing"},{"key":"1517_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1101144","volume":"13","author":"S Mazhar","year":"2022","unstructured":"Mazhar, S. et al. In vitro and in silico assessment of probiotic and functional properties of Bacillus subtilis DE111((R)). Front. Microbiol. 13, 1101144 (2022).","journal-title":"Front. Microbiol."},{"key":"1517_CR24","first-page":"943","volume":"10","author":"LR Lopetuso","year":"2016","unstructured":"Lopetuso, L. R., Scaldaferri, F., Franceschi, F. & Gasbarrini, A. Bacillus clausii and gut homeostasis: state of the art and future perspectives. Expert Rev. Gastroenterol. Hepatol. 10, 943\u2013948 (2016).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"1517_CR25","first-page":"16","volume":"13","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. Weizmannia coagulans: an ideal probiotic for gut health. Food Sci. Hum. Wellness 13, 16\u201326 (2024).","journal-title":"Food Sci. Hum. Wellness"},{"key":"1517_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbio.2020.100675","volume":"36","author":"L Sui","year":"2020","unstructured":"Sui, L. et al. In vitro assessment of probiotic and functional properties of Bacillus coagulans T242. Food Biosci. 36, 100675 (2020).","journal-title":"Food Biosci."},{"key":"1517_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1302480","volume":"14","author":"S Mazhar","year":"2023","unstructured":"Mazhar, S. et al. In vitro safety and functional characterization of the novel Bacillus coagulans strain CGI314. Front. Microbiol. 14, 1302480 (2023).","journal-title":"Front. Microbiol."},{"key":"1517_CR28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3920\/BM2017.0129","volume":"9","author":"MR Sudha","year":"2018","unstructured":"Sudha, M. R., Jayanthi, N., Aasin, M., Dhanashri, R. D. & Anirudh, T. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study. Benef. Microbes 9, 563\u2013572 (2018).","journal-title":"Benef. Microbes"},{"key":"1517_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48554-x","volume":"9","author":"RS Madempudi","year":"2019","unstructured":"Madempudi, R. S., Ahire, J. J., Neelamraju, J., Tripathi, A. & Nanal, S. Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults. Sci. Rep. 9, 12210 (2019).","journal-title":"Sci. Rep."},{"key":"1517_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s13312-023-2907-0","volume":"60","author":"P Lojanatorn","year":"2023","unstructured":"Lojanatorn, P. et al. Efficacy of Bacillus clausii in pediatric functional constipation: a pilot of a randomized, double-blind, placebo-controlled trial. Indian Pediatr. 60, 453\u2013458 (2023).","journal-title":"Indian Pediatr."},{"key":"1517_CR31","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.chest.2020.03.010","volume":"158","author":"X Wang","year":"2020","unstructured":"Wang, X. & Ji, X. Sample size estimation in clinical research: from randomized controlled trials to observational studies. Chest 158, S12\u2013s20 (2020).","journal-title":"Chest"},{"key":"1517_CR32","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1053\/j.gastro.2016.02.032","volume":"150","author":"DA Drossman","year":"2016","unstructured":"Drossman, D. A. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology 150, 1262\u20131279 (2016).","journal-title":"Gastroenterology"},{"key":"1517_CR33","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-023-06480-z","volume":"621","author":"A Mertens","year":"2023","unstructured":"Mertens, A. et al. Child wasting and concurrent stunting in low- and middle-income countries. Nature 621, 558\u2013567 (2023).","journal-title":"Nature"},{"key":"1517_CR34","doi-asserted-by":"crossref","unstructured":"Shokouhi, N., Mohammadi, S., Ghanbari, Z. & Montazeri, A. Development of a new version of the Bristol Stool Form Scale: translation, content validity, face validity, and reliability of the Persian version. BMJ Open Gastroenterol. 9, e001017 (2022).","DOI":"10.1136\/bmjgast-2022-001017"},{"key":"1517_CR35","doi-asserted-by":"publisher","unstructured":"Hornberger, L. L. et al. Identification and management of eating disorders in children and adolescents. Pediatrics. 147 https:\/\/doi.org\/10.1542\/peds.2020-040279 (2021).","DOI":"10.1542\/peds.2020-040279"},{"key":"1517_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56627-9","volume":"14","author":"HT Dang","year":"2024","unstructured":"Dang, H. T. et al. Promising clinical and immunological efficacy of Bacillus clausii spore probiotics for supportive treatment of persistent diarrhea in children. Sci. Rep. 14, 6422 (2024).","journal-title":"Sci. Rep."},{"key":"1517_CR37","first-page":"225","volume":"8","author":"M Slivnik","year":"2020","unstructured":"Slivnik, M. et al. Effect of daily Bacillus subtilis DE111 \u00ae intake on gastrointestinal health and respiratory infections in children attending day-care: a randomised, parallel, double-blind, placebo-controlled study. J. Prob. Health 8, 225 (2020).","journal-title":"J. Prob. Health"},{"key":"1517_CR38","first-page":"86","volume":"4","author":"A Dhongade","year":"2022","unstructured":"Dhongade, A. et al. The efficacy and safety of a Bacillus probiotic combination for the treatment of acute diarrhea in children: a double-blind, randomized, placebo-controlled multicentric study. Pediatr. Infect. Dis. 4, 86\u201391 (2022).","journal-title":"Pediatr. Infect. Dis."},{"key":"1517_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106614","volume":"187","author":"M Noormohammadi","year":"2023","unstructured":"Noormohammadi, M. et al. The effect of probiotic and synbiotic supplementation on appetite-regulating hormones and desire to eat: a systematic review and meta-analysis of clinical trials. Pharmacol. Res. 187, 106614 (2023).","journal-title":"Pharmacol. Res."},{"key":"1517_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-29095-w","volume":"13","author":"S Nuzhat","year":"2023","unstructured":"Nuzhat, S. et al. Effects of probiotic and synbiotic supplementation on ponderal and linear growth in severely malnourished young infants in a randomized clinical trial. Sci. Rep. 13, 1845 (2023).","journal-title":"Sci. Rep."},{"key":"1517_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41043-015-0010-4","volume":"34","author":"OJ Onubi","year":"2015","unstructured":"Onubi, O. J., Poobalan, A. S., Dineen, B., Marais, D. & McNeill, G. Effects of probiotics on child growth: a systematic review. J. Health Popul. Nutr. 34, 8 (2015).","journal-title":"J. Health Popul. Nutr."},{"key":"1517_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.578386","volume":"12","author":"F Cristofori","year":"2021","unstructured":"Cristofori, F. et al. Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body. Front. Immunol. 12, 578386 (2021).","journal-title":"Front. Immunol."},{"key":"1517_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00281-024-01027-4","volume":"47","author":"P Gao","year":"2024","unstructured":"Gao, P., Morita, N. & Shinkura, R. Role of mucosal IgA antibodies as novel therapies to enhance mucosal barriers. Semin. Immunopathol. 47, 1 (2024).","journal-title":"Semin. Immunopathol."},{"key":"1517_CR44","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s12519-018-0144-8","volume":"14","author":"C Cirali","year":"2018","unstructured":"Cirali, C., Ulusoy, E., Kume, T. & Arslan, N. Elevated serum neopterin levels in children with functional constipation: association with systemic proinflammatory cytokines. World J. Pediatr. 14, 448\u2013453 (2018).","journal-title":"World J. Pediatr."},{"key":"1517_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02301-8","volume":"20","author":"GL Burns","year":"2022","unstructured":"Burns, G. L., Talley, N. J. & Keely, S. Immune responses in the irritable bowel syndromes: time to consider the small intestine. BMC Med. 20, 115 (2022).","journal-title":"BMC Med."},{"key":"1517_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.595531","volume":"8","author":"D Avelar Rodriguez","year":"2020","unstructured":"Avelar Rodriguez, D., Popov, J., Ratcliffe, E. M. & Toro Monjaraz, E. M. Functional constipation and the gut microbiome in children: preclinical and clinical evidence. Front. Pediatr. 8, 595531 (2020).","journal-title":"Front. Pediatr."},{"key":"1517_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201801187","volume":"63","author":"M Zhuang","year":"2019","unstructured":"Zhuang, M., Shang, W., Ma, Q., Strappe, P. & Zhou, Z. Abundance of probiotics and butyrate-production microbiome manages constipation via short-chain fatty acids production and hormones secretion. Mol. Nutr. Food Res. 63, e1801187 (2019).","journal-title":"Mol. Nutr. Food Res."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01517-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01517-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01517-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:02:45Z","timestamp":1773828165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01517-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1517"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01517-6","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"26 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LiveSpo Preg-Mom and LiveSpo Kids were produced by LiveSpo Pharma Ltd., of which A.H.N. is the founder and scientific director. In this study, A.H.N. provided the study products and contributed only to general scientific discussions, with no involvement in study design, implementation, data collection, or analysis. A.T.V.N. works for ANABIO R&D and serves as a scientific consultant for LiveSpo Pharma Ltd. A.T.V.N. contributed solely to conceptualization, methodology, and manuscript editing, without involvement in trial execution or data handling. D.P.L. is employed by ANABIO R&D and participated only in laboratory analyses on coded samples, ensuring blinding and data integrity. All remaining authors declare no competing interests. LiveSpo Pharma Ltd. had no role in study design, data collection, data analysis, data interpretation, or manuscript preparation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}